4116.TWO BenQ Medical Technology
- Market cap
- TWD 1.80B
- P/E
- 15.3x
- P/B
- 1.71x
- ROE
- 13.0%
- Dividend yield
- 4.09%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 4116.TWO undervalued?
Graham number4116.TWO trades 7.9% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
BenQ Medical Technology fundamental analysis
No fundamental analysis for BenQ Medical Technology yet.
BenQ Medical Technology stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About BenQ Medical Technology
BenQ Medical Technology Corporation engages in the manufacture, installation, maintenance, and repair of medical device and various medical equipment in Taiwan, Mainland China, India, and internationally. It operates through R&D and Manufacturing, and Medical Services segments. The company offers wholesale and retail sales of medical device, medical equipment, pharmaceutical, health food, and the leasing business of medical equipment and management consulting services. It al…
Full company profileBenQ Medical Technology financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
BenQ Medical Technology annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 1.04B | 1.23B | 1.38B | 1.40B | 1.46B | 2.95B | 4.54B | 4.77B | 5.25B | 5.51B |
| Gross Profit | 382M | 466M | 548M | 552M | 512M | 860M | 1.34B | 1.45B | 1.69B | 1.78B |
| Operating Income | 69.2M | 93.6M | 124M | 110M | 67.5M | 287M | 365M | 333M | 346M | 322M |
| EBITDA | 109M | 148M | 198M | 195M | 169M | 477M | 630M | 619M | 648M | 731M |
| Net Income | 46.6M | 66.7M | 75.4M | 62.1M | 28.8M | 180M | 115M | 105M | 78.2M | 143M |
| EPS | 1.05 | 1.50 | 1.68 | 1.39 | 0.65 | 4.02 | 2.57 | 2.35 | 1.75 | 3.21 |
| Balance Sheet | ||||||||||
| Total Assets | 1.54B | 1.68B | 1.69B | 1.79B | 1.96B | 3.40B | 4.71B | 5.27B | 5.45B | 5.52B |
| Total Liabilities | 476M | 589M | 585M | 678M | 856M | 1.66B | 2.53B | 2.97B | 3.12B | 3.24B |
| Shareholders' Equity | 1.02B | 1.04B | 1.05B | 1.05B | 1.04B | 1.20B | 1.10B | 1.12B | 1.13B | 1.10B |
| Cash & Short-term Investments | 225M | 318M | 296M | 343M | 421M | 839M | 831M | 863M | 949M | 821M |
| Total Debt | - | - | 241M | 303M | 492M | 852M | - | - | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | 73.0M | 126M | 169M | 151M | 121M | 379M | 442M | 222M | 359M | 357M |
| Capital Expenditure | 112M | 31.4M | 21.1M | 42.4M | 32.9M | 60.1M | 139M | 175M | 99.2M | 50.5M |
| Free Cash Flow | -41.3M | 87.7M | 148M | 109M | 88.4M | 319M | 303M | 46.7M | 260M | 306M |
| Ratios | ||||||||||
| ROE | 4.6% | 6.4% | 7.2% | 5.9% | 2.8% | 15.0% | 10.4% | 9.3% | 6.9% | 13.0% |
| ROA | 3.0% | 4.0% | 4.5% | 3.5% | 1.5% | 5.3% | 2.4% | 2.0% | 1.4% | 2.6% |
| Net Profit Margin | 4.5% | 5.4% | 5.5% | 4.4% | 2.0% | 6.1% | 2.5% | 2.2% | 1.5% | 2.6% |
| Debt to Equity | - | - | 0.23x | 0.29x | 0.47x | 0.71x | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
BenQ Medical Technology dividends
- Dividend yield
- 4.09%
- Forward dividend
- 2.00 TWD
- Payout ratio
- 94.1%
- Ex-dividend date
- Jul 1, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | TWD 73.5M | 1.65 | 94.1% |
| 2024 | TWD 89.1M | 2.00 | 85.0% |
| 2023 | TWD 93.6M | 2.10 | 81.7% |
| 2022 | TWD 22.3M | 0.50 | 12.4% |
| 2021 | TWD 44.6M | 1.00 | 154.5% |
| 2020 | TWD 60.2M | 1.34 | 97.0% |
| 2019 | TWD 60.2M | 1.34 | 79.8% |
| 2018 | TWD 44.6M | 1.00 | 66.8% |
| 2017 | TWD 31.0M | 0.70 | 66.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns BenQ Medical Technology
- Insiders 58.25%
- Institutions 0.00%
- Public & others 41.75%
- Shares outstanding 44.6M
- Free float 21.0M
BenQ Medical Technology company profile
- Company name
- BenQ Medical Technology
- Ticker
- 4116.TWO
- ISIN
- TW0004116009
- Exchange
- Taiwan OTC Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Fiscal year end
- December
- Address
- No. 46, Zhouzi Street, Taipei, Taiwan, 11493
- Phone
- 886 2 8797 5533
- Website
- benqmedicaltech.com
About BenQ Medical Technology
BenQ Medical Technology Corporation engages in the manufacture, installation, maintenance, and repair of medical device and various medical equipment in Taiwan, Mainland China, India, and internationally. It operates through R&D and Manufacturing, and Medical Services segments. The company offers wholesale and retail sales of medical device, medical equipment, pharmaceutical, health food, and the leasing business of medical equipment and management consulting services. It also offers electric hydraulic and manual hydraulic operating table, and operating table accessories; adjustable color temperature and single-color temperature surgical light; fixed pendant, electric pendant, and ICU suspension bridge; diagnostic display, and surgical display monitor; and portable ultrasound units, as well as it offers integrated operating system solutions. The company was formerly known as Trident Medical Corp. and changed its name to BenQ Medical Technology Corporation in June 2011. BenQ Medical Technology Corporation was incorporated in 1989 and is headquartered in Taipei, Taiwan.
BenQ Medical Technology management
2- Mr. Er-An ChuPresident, Acting Spokesperson & Representative Institutional Director
- Zhihua LiuAccounting Supervisor